Rankings
▼
Calendar
▼
TLX Q2 2000 Earnings Report — Telix Pharmaceuticals Limited Revenue & Financial Results | Market Cap Arena
Telix Pharmaceuticals Limited
TLX
Q2 2000 Earnings
Reported June 29, 2000
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Metric
Q2 2000
Q1 2000
Q2 1999
QoQ Change
YoY Change
Revenue
$0
—
$0
—
—
Op. Income
-$355.2K
—
-$206.5K
—
-72.0%
EPS (Diluted)
$0.00
—
$0.00
—
NaN%
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$0
GROSS PROFIT
$0
R&D Expenses
$0
Selling & Marketing
$0
General & Administrative
$0
SG&A Expenses
$0
Other Expenses
-$355.2K
Operating Expenses
-$355.2K
Cost & Expenses
-$355.2K
OPERATING INCOME
-$355.2K
Interest Income
$0
Interest Expense
$0
Other Income/Expenses
$177.6K
INCOME BEFORE TAX
-$177.6K
Income Tax Expense
-$177.6K
Net Income from Continuing Ops
$0
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
$0
Net Income Deductions
$0
BOTTOM LINE NET INCOME
$0
D&A
$0
EBIT
$0
EBITDA
-$355.2K
EPS
$0
EPS Diluted
$0
marketcaparena.com
← FY 2000
TLX Overview
Q4 2000 →